Article Text

PDF
FRI0388 Ussefulnes of Bvas and Ffs at Diagnosis To Predict Survival in Anca Associated Vasculitis (AAV)
  1. R. Solans-Laqué1,
  2. M. Rodriguez-Carballeira2,
  3. J. Rios3,
  4. L. Saez4,
  5. G. Fraile5,
  6. X. Solanich6,
  7. F. Pasquau7,
  8. J. Oristrell8,
  9. E. Fonseca9,
  10. J.L. Callejas10,
  11. M. Zamora11,
  12. M.J. del Castillo12,
  13. B. Frutos13,
  14. L. Caminal14,
  15. M. Abdilla15,
  16. P. Fanlo16,
  17. I. Garcia-Sanchez17,
  18. B. Sopeña18,
  19. M. Lopez-Dupla19,
  20. A. Perez-Iglesias20,
  21. on behalf of REVAS Group from GEAS-SEMI
  1. 1Internal Medicine, Vall Hebron University Hospital, Barcelona
  2. 2Internal Medicine, H Mutua Terrassa, Terrassa
  3. 3Internal Medicine, H La Paz, Madrid
  4. 4Internal Medicine, H Miguel Servet, Zaragoza
  5. 5Internal Medicine, H Ramon y Cajal, Madrid
  6. 6Internal Medicine, H Bellvitge, Barcelona
  7. 7Internal Medicine, H Marina Baixa, Alicante
  8. 8Internal Medicine, H Parc Tauli, Sabadell
  9. 9Internal Medicine, H Cabueñes, Asturias
  10. 10Internal Medicine, H San Cecilio
  11. 11Internal Medicine, H Virgen Nieves, Granada
  12. 12Internal Medicine, H Virgen del Rocio, Sevilla
  13. 13Internal Medicine, H Fuenlabrada, Madrid
  14. 14Internal Medicine, HUCA, Oviedo
  15. 15Internal Medicine, H la Rivera, Valencia
  16. 16Internal Medicine, H Clinica Navarra, Navarra
  17. 17Internal Medicine, H Infanta Leonor, Madrid
  18. 18Internal Medicine, CHUVI, Vigo
  19. 19Internal Medicine, H Joan XXIII, Tarragona
  20. 20Internal Medicine, H Orense, Orense, Spain

Abstract

Background The Birmingham Vasculitis Activity Score (BVAS), and the Five Factor Score (FFS) at the time of diagnosis have been shown useful to asses prognosis in AAV (1,2), but few studies have been done comparing these tools to predict survival

Objectives To compare the usefulness of BVAS vs 3, 1996 FFS and 2009 FFS at the time of diagnosis, to predict survival in a large cohort of patients with AAV from Spain

Methods multicenter retrospective-longitudinal study that included patients diagnosed with AAV between Jan1995 and Nov13 in 20 Hospitals from Spain (REVAS Study). Patient survival was assessed by life-table analysis using the Kaplan-Meier method. Statistical analysis was done using SPSS vs21

Results 455 patients were included: 188 (41.3%) GPA, 167 (36.7%) MPA and 100 (22%) EGPA; 50.8% were men. Mean age at diagnosis was 55.7±17.2 y. ANCA were positive in 86.8% of cases: 35.8% C-ANCA and 51% P-ANCA. Median time to diagnosis was 4 weeks (IQR 10). Median follow-up time was 80 months (IQR 105) for global population. Renal involvement was present in 61.5% of cases, lung involvement in 54.7%, pulmonary-renal syndrome in 16.9%, neurological involvement in 34.5%, and cardiac involvement in 12.7%. ENT was observed in 44.8% of cases and eye involvement in 18.9%. Mean BVAS at diagnosis was 17.7±7.7; 1996FFS was ≤1 in 390 (85.8%) patients, and 2009FFS was ≤2 in 361 (79.4%). All patients received oral corticoids, 342 (75.1%) cyclophosphamide (49.7% IV and 50.3% oral), and 6.6% biological therapy. Dialysis was required in 16.4% of cases. During the follow-up, 39.1% of patients suffered bacterial infections, 9.2% sepsis,12.7% opportunistic infections and 5.3% neoplasms. One hundred thirty (28.6%) died:74 (44.3%) with PAM, 42 (22.3%) with GPA and 14 (14%) with EGPA (p<0.001). Univariate analysis showed that BVAS, 1996FFS and 2009FFS at diagnosis were significantly related to death (p<0.001). A multifactorial Cox regression analysis including the three activity scores confirmed that all of them were statistically related to survival rate but the stronger predictor of poor prognosis was the 2009FFS with a HR 2.7. This result was confirmed by curve ROC: 2009FFS showed the greater area under the curve (75%), in front of 1996FFS (66%) and BVAS (62%)

Conclusions BVAS and FFS at diagnosis are signifivantly related to survival in AAV, but the stronger predictor of survival is the 2009 FFS.

  1. Merkel P, Cuthbertson D, et al. Comparison of disease activity measures for ANCA-associated vasculitis. ARD 2009;68:103–6

  2. Guillevin L, Seror R, et al. The Five-Factor Score Revisited Assessment of Prognoses of Systemic Necrotizing Vasculitides. Medicine 2011;90:19–27

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.